世界の血液市場予測2019-2028

◆英語タイトル:GLOBAL BLOOD MARKET FORECAST 2019-2028
◆商品コード:INK20AG008
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年8月
◆ページ数:189
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥262,500見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥315,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算¥472,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、血液の世界市場について調査を行い、調査手法、エグゼクティブサマリー、市場動向、主要分析、製品別(全血採取、ソースプラズマ収集、血液治療、血液型検査、血液スクリーニング)分析、エンドユーザー別分析、地域別分析、企業情報などをまとめております。
・調査手法
・エグゼクティブサマリー
・市場動向
・主要分析
・血液の世界市場規模:製品別(全血採取、ソースプラズマ収集、血液治療、血液型検査、血液スクリーニング)
・血液の世界市場規模:エンドユーザー別
・血液の世界市場規模:地域別
・企業情報







【レポートの概要】

KEY FINDINGS
The global blood market is estimated to grow with a CAGR of 4.16% across the forecast years of 2019 to 2028. Primary factors attributed to driving the market growth include, the increase in the worldwide demand for blood and blood-related products, the growing geriatric population, rise in blood and plasma donations, developments in blood transfusion and screening instruments, and the introduction of government regulations for blood screening.

MARKET INSIGHTS
The global blood market entails the sale of whole blood as well as blood components using diverse mediums like, hospitals, and blood banks, among others. Blood transfusion is typically performed in medical facilities during disease treatments and surgeries, and involves the red blood cells’ transfer from one person to another. The donor’s blood is collected and then categorized in terms of requirements and components. Since the transfusion process only requires blood components, an entire unit of blood is seldom used.
In recent years, there has been a rapid increase in the geriatric population across the world. Consequently, they are more susceptible to numerous chronic conditions like cardiovascular diseases, type 2 diabetes, arthritis, and obesity. The elderly are also prone to distinct types of cancers like prostate and stomach cancer. Thus, the predisposition to various medical complications, leads to the need for blood and source plasma treatments. As a result, the rise in geriatric populace is expected to raise the demand for blood and plasma collecting reagents and instruments and bolster the market growth.

REGIONAL INSIGHTS
The geographical analysis of the global blood market growth includes the Asia Pacific, North America, Europe, and the rest of the world. Developing economies in the Asia Pacific blood market is witnessing an increasing number of patients suffering from chronic ailments and developments within healthcare institutions. As a result, the region offers profitable opportunities for key market players, especially in the blood collection equipment division.

COMPETITIVE ANALYSIS
The industrial rivalry within the global blood market is estimated to be high across the forecast period. The intense competition is attributed to the rise in healthcare expenses, and the increased prevalence of chronic diseases that require a blood transfusion. Some of the renowned companies in the market include, Bio-Rad Laboratories Inc, Immucor Inc, Abbott Laboratories, CSL Limited, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. INCREASING DEMAND FOR BLOOD AND OTHER BLOOD RELATED PRODUCTS ACROSS THE WORLD
3.2.2. SURGE IN GERIATRIC POPULATION ACROSS THE GLOBE
3.2.3. RISE IN BLOOD DONATIONS AND PLASMA DONATIONS
3.2.4. PROMISING GOVERNMENT REGULATIONS FOR BLOOD SCREENING
3.2.5. PROGRESSION IN BLOOD TRANSFUSION AND BLOOD SCREENING INSTRUMENTS
3.3. KEY RESTRAINTS
3.3.1. HIGH COST OF ADVANCED BLOOD COLLECTION DEVICES
3.3.2. DEARTH OF SKILLED LABORATORY PROFESSIONALS
4. KEY ANALYTICS
4.1. KEY INVESTMENT INSIGHTS
4.2. PORTER’S FIVE FORCE ANALYSIS
4.2.1. BUYER POWER
4.2.2. SUPPLIER POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE
4.5. IMPACT OF COVID – BLOOD MARKET
5. MARKET BY PRODUCT
5.1. WHOLE BLOOD COLLECTION
5.1.1. WHOLE BLOOD COLLECTION SYSTEMS
5.1.2. WHOLE BLOOD COLLECTION REAGENTS
5.2. SOURCE PLASMA COLLECTION
5.2.1. SOURCE PLASMA COLLECTION SYSTEMS
5.2.2. SOURCE PLASMA COLLECTION REAGENTS
5.3. BLOOD THERAPEUTICS
5.3.1. INTRAVENOUS IMMUNOGLOBULIN (IVIG)
5.3.2. ALBUMIN
5.3.3. HYPERIMMUNE
5.3.4. FACTOR VIII
5.3.5. FACTOR IX
5.3.6. OTHER BLOOD THERAPEUTICS
5.4. BLOOD TYPING
5.4.1. BLOOD TYPING SYSTEMS
5.4.2. BLOOD TYPING REAGENTS
5.5. BLOOD SCREENING
5.5.1. BLOOD SCREENING SYSTEMS
5.5.2. BLOOD SCREENING REAGENTS
5.6. BLOOD PROCESSING EQUIPMENT
5.6.1. BLOOD PROCESSING EQUIPMENT SYSTEMS
5.6.2. BLOOD PROCESSING EQUIPMENT REAGENTS
6. MARKET BY END-USER
6.1. BLOOD & BLOOD COMPONENT BANKS
6.2. DIAGNOSTIC LABORATORIES
6.3. AMBULATORY SURGICAL CENTERS
6.4. HOSPITALS
6.5. OTHER END-USERS
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. UNITED STATES
7.1.2. CANADA
7.2. EUROPE
7.2.1. UNITED KINGDOM
7.2.2. GERMANY
7.2.3. FRANCE
7.2.4. ITALY
7.2.5. RUSSIA
7.2.6. BELGIUM
7.2.7. POLAND
7.2.8. REST OF EUROPE
7.3. ASIA PACIFIC
7.3.1. CHINA
7.3.2. JAPAN
7.3.3. INDIA
7.3.4. SOUTH KOREA
7.3.5. INDONESIA
7.3.6. THAILAND
7.3.7. VIETNAM
7.3.8. AUSTRALIA & NEW ZEALAND
7.3.9. REST OF ASIA PACIFIC
7.4. REST OF WORLD
7.4.1. LATIN AMERICA
7.4.2. MIDDLE EAST & AFRICA
8. COMPANY PROFILES
8.1. ABBOTT LABORATORIES
8.2. BIO-RAD LABORATORIES INC
8.3. CSL LIMITED (CSL BEHRING)
8.4. F HOFFMANN-LA ROCHE LTD
8.5. GRIFOLS INTERNATIONAL SA
8.6. HAEMONETICS CORPORATION
8.7. MERCK & CO INC
8.8. NOVO NORDISK A/S
8.9. BAXTER INTERNATIONAL INC
8.10. BECTON DICKINSON AND COMPANY
8.11. FRESENIUS KABI AG
8.12. ORTHO CLINICAL DIAGNOSTICS
8.13. TERUMO CORPORATION (TERUMO BCT INC)
8.14. IMMUCOR INC

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – BLOOD
TABLE 2: GLOBAL BLOOD MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 3: GLOBAL BLOOD MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 4: GLOBAL WHOLE BLOOD COLLECTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: GLOBAL WHOLE BLOOD COLLECTION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 6: GLOBAL WHOLE BLOOD COLLECTION SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: GLOBAL WHOLE BLOOD COLLECTION SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 8: GLOBAL WHOLE BLOOD COLLECTION REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: GLOBAL WHOLE BLOOD COLLECTION REAGENTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 10: GLOBAL SOURCE PLASMA COLLECTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 11: GLOBAL SOURCE PLASMA COLLECTION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 12: GLOBAL SOURCE PLASMA COLLECTION SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 13: GLOBAL SOURCE PLASMA COLLECTION SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 14: GLOBAL SOURCE PLASMA COLLECTION REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 15: GLOBAL SOURCE PLASMA COLLECTION REAGENTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 16: GLOBAL BLOOD THERAPEUTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 17: GLOBAL BLOOD THERAPEUTICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 18: GLOBAL INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 19: GLOBAL INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 20: GLOBAL ALBUMIN MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 21: GLOBAL ALBUMIN SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 22: GLOBAL HYPERIMMUNE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 23: GLOBAL HYPERIMMUNE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 24: GLOBAL FACTOR VIII MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 25: GLOBAL FACTOR VIII MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 26: GLOBAL FACTOR IX MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 27: GLOBAL FACTOR IX MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 28: GLOBAL OTHER BLOOD THERAPEUTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 29: GLOBAL OTHER BLOOD THERAPEUTICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 30: GLOBAL BLOOD TYPING MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 31: GLOBAL BLOOD TYPING MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLI
ON)
TABLE 32: GLOBAL BLOOD TYPING SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 33: GLOBAL BLOOD TYPING SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 34: GLOBAL BLOOD TYPING REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 35: GLOBAL BLOOD TYPING REAGENTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 36: GLOBAL BLOOD SCREENING MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 37: GLOBAL BLOOD SCREENING MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 38: GLOBAL BLOOD SCREENING SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 39: GLOBAL BLOOD SCREENING SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 40: GLOBAL BLOOD SCREENING REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 41: GLOBAL BLOOD SCREENING REAGENTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 42: GLOBAL BLOOD PROCESSING EQUIPMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 43: GLOBAL BLOOD PROCESSING EQUIPMENT MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 44: GLOBAL BLOOD PROCESSING EQUIPMENT SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 45: GLOBAL BLOOD PROCESSING EQUIPMENT SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 46: GLOBAL BLOOD PROCESSING EQUIPMENT REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 47: GLOBAL BLOOD PROCESSING EQUIPMENT REAGENTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 48: GLOBAL BLOOD MARKET, BY END-USERS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 49: GLOBAL BLOOD MARKET, BY END-USERS, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 50: GLOBAL BLOOD & BLOOD COMPONENT BANKS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 51: GLOBAL BLOOD & BLOOD COMPONENT BANKS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 52: GLOBAL DIAGNOSTIC LABORATORIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 53: GLOBAL DIAGNOSTIC LABORATORIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 54: GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 55: GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 56: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 57: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 58: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 59: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 60: GLOBAL BLOOD MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 61: GLOBAL BLOOD MARKET, BY GEOGRAPHY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 62: NORTH AMERICA BLOOD MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 63: NORTH AMERICA BLOOD MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 64: EUROPE BLOOD MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 65: EUROPE BLOOD MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 66: ASIA PACIFIC BLOOD MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 67: ASIA PACIFIC BLOOD MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 68: REST OF WORLD BLOOD MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 69: REST OF WORLD BLOOD MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の血液市場予測2019-2028]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆